These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9220214)

  • 21. Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder.
    Mokhber N; Azarpazhooh MR; Khajehdaluee M; Velayati A; Hopwood M
    Psychiatry Clin Neurosci; 2010 Apr; 64(2):128-33. PubMed ID: 20132529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo.
    Pecknold JC; Matas M; Howarth BG; Ross C; Swinson R; Vezeau C; Ungar W
    Can J Psychiatry; 1989 Nov; 34(8):766-71. PubMed ID: 2684380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers.
    Cinciripini PM; Lapitsky L; Seay S; Wallfisch A; Meyer WJ; van Vunakis H
    J Clin Psychopharmacol; 1995 Jun; 15(3):182-91. PubMed ID: 7635995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of lesopitron in outpatients with generalized anxiety disorder.
    Fresquet A; Sust M; Lloret A; Murphy MF; Carter FJ; Campbell GM; Marion-Landais G
    Ann Pharmacother; 2000 Feb; 34(2):147-53. PubMed ID: 10676820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies.
    Gammans RE; Stringfellow JC; Hvizdos AJ; Seidehamel RJ; Cohn JB; Wilcox CS; Fabre LF; Pecknold JC; Smith WT; Rickels K
    Neuropsychobiology; 1992; 25(4):193-201. PubMed ID: 1454160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buspirone: multicenter efficacy study.
    Wheatley D
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder.
    DeMartinis N; Rynn M; Rickels K; Mandos L
    J Clin Psychiatry; 2000 Feb; 61(2):91-4. PubMed ID: 10732655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.
    Delle Chiaie R; Pancheri P; Casacchia M; Stratta P; Kotzalidis GD; Zibellini M
    J Clin Psychopharmacol; 1995 Feb; 15(1):12-9. PubMed ID: 7714222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buspirone: anxiolytic?
    Pecknold JC; Familamiri P; Chang H; Wilson R; Alarcia J; McClure DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):639-42. PubMed ID: 2868495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buspirone in the long-term treatment of generalized anxiety disorder.
    Feighner JP
    J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials.
    Strawn JR; Mills JA; Cornwall GJ; Mossman SA; Varney ST; Keeshin BR; Croarkin PE
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):2-9. PubMed ID: 28846022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
    Llorca PM; Spadone C; Sol O; Danniau A; Bougerol T; Corruble E; Faruch M; Macher JP; Sermet E; Servant D
    J Clin Psychiatry; 2002 Nov; 63(11):1020-7. PubMed ID: 12444816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression.
    Robinson DS; Rickels K; Feighner J; Fabre LF; Gammans RE; Shrotriya RC; Alms DR; Andary JJ; Messina ME
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):67S-76S. PubMed ID: 2198303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability.
    Schneider RB; Auinger P; Tarolli CG; Iourinets J; Gil-Díaz MC; Richard IH
    Parkinsonism Relat Disord; 2020 Dec; 81():69-74. PubMed ID: 33070009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A placebo-controlled trial of buspirone for the treatment of marijuana dependence.
    McRae-Clark AL; Carter RE; Killeen TK; Carpenter MJ; Wahlquist AE; Simpson SA; Brady KT
    Drug Alcohol Depend; 2009 Nov; 105(1-2):132-8. PubMed ID: 19699593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHD.
    Sutherland SM; Adler LA; Chen C; Smith MD; Feltner DE
    J Clin Psychiatry; 2012 Apr; 73(4):445-50. PubMed ID: 22313788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.